Sodium Valproate in Sydenham's Chorea
Neurol 35:114-115, Dhanaraj,M.,et al, 1985
Naproxen in Prophylaxis of Migraine
Arch Neurol 42:582-584, Ziegler,D.K.,et al, 1985
Pathophysiological & Prognostic Significance of Cerebrospinal Fluid Lactate in Cerebral Malaria
Lancet 1:776-778, White,N.J.,et al, 1985
Carcinoid Carcinomatous Meningitis
Ann Int Med 102:779-782, Nagourney,R.A.,et al, 1985
Reye's Syndrome Associated with Long-Term Aspirin Therapy
JAMA 251:754-756, Young,R.S.K.,et al, 1984
The Cerebrohepatorenal (Zellweger) Syndrome
NEJM 310:1141-1146, Moser,A.E.,et al, 1984
Adrenoleukodystrophy:Survey of 303 Cases:Biochemistry, Diagnosis, & Therapy
Ann Neurol 16:628-641, Moser,H.W.,et al, 1984
Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis
NEJM 311:27-34, 100-1051984., Kistler,J.P.,et al, 1984
Antifibrinolytic Treatment in Subarachnoid Hemorrhage
NEJM 311:432-437, Vermeulen,M.,et al, 1984
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, & Strokelike Episodes:A Distinctive Clinical Syndrome
Ann Neurol 16:481-488, Pavlakis,S.G.,et al, 1984
Adrenoleukodystrophy:Clinical & Biochemical Manifestations in Carriers
Neurol 34:798-801, O'Neill,B.P.,et al, 1984
Mitral Valve Prolapse & Cerebral Ischemic Events in Young Patients
Neurol 34:784-787, Jackson,A.C.,et al, 1984
Hyperekplexia:A Syndrome of Pathological Startle Responses
Ann Neurol 15:36-41, Saenz-Lope,E.,et al, 1984
Entrapment Neuropathy Caused by Tophaceous Gout
J Hand Surg 9-B:331-332, Akizuki,S.&Matsui,T., 1984
Multifocal Central Nervous System Damage Caused by Toluene Abuse
Neurol 33:1337-1340, Lazar,R.B.,et al, 1983
Gouty Neuropathy
Arch Neurol 40:823-824, Delaney,P., 1983
Treatment after Transient Ischemic Attacks:A Comparison between Anticoagulant Drug & Inhibition of Platelet Aggrega
Stroke 14:677-681, Garde,A.,et al, 1983
Phytanic Acid Storage Disease:Hearing Maintained After 15 Years of Dietary Treatment
Neurol 33:237-240, Djupesland,G.,et al, 1983
Hepatic & Cerebral Pathology Findings in Children with Fatal Salicylate Intoxication
Lancet 1:326-329, Starko,K.M.,et al, 1983
Serum Folate Concentra. During Pregnancy in Women with Epilepsy:Relation to Antiepileptic Drug Concentrations
BMJ 287:577-579, Hiilesmaa,V.K.,et al, 1983
Safe Readministration of Valproate after an Episode of Hepatotoxicity
Ann Neurol 13:688, Ramsay,R.E., 1983
Valproic Acid & Fetal Abnormality
BMJ 286:190, Bailey,C.J.,et al, 1983
Valproic Acid Therapy for Complex Partial Seizures, Its Efficacy & Toxic Effects
Arch Neurol 40:135-137, Bruni,J.,et al, 1983
Plasma Concentrations of Sodium Valproate:Their Clinical Value
Ann Neurol 14:38-42, Turnbull,D.M.,et al, 1983
Valproic Acid & Intractable Seizures in Severely Brain-Damaged Patients
Neurol 33:99-101, Chayasirisobhon,S.,et al, 1983
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
Arch Neurol 40:797-802, Rowan,A.J.,et al, 1983
Comparison of Valproic Acid & Phenytoin in Newly Diagnosed Tonic-Clonic Seizures
Neurol 33:1474-1476, Wilder,B.J.,et al, 1983
Adult Inorganic Lead Intoxication:Presentation of 31 New Cases & a Review of Recent Advances in the Literature
Medicine 62:221-247, Cullen,M.R.,et al, 1983
CSF Lactate in Diseases of the CNS
Arch Int Med 143:85-87, Jordan,G.W.,et al, 1983
"AICLA"Controlled Trial of Aspirin & Dipyridamole in the Prevention of Athero-Thrombotic Cerebral Ischemia
Stroke 14:5-14, Bousser,M.G.,et al, 1983
Acetylsalicylic Acid in the Prevention of Strokes in Patients with Reversible Cerebral Ischemic Attacks
Stroke 14:15-22, Sorensen,P.S.,et al, 1983
Abnormal Brainstem Auditory Evoked Potentials in Chronic Paint Sniffers
Ann Neurol 12:553-556, Metrick,S.A.,et al, 1982
Sodium Valproate-induced Hyperammonemia Without Clinical Hepatic Dysfunction
Neurol 32:206-208, Zaret,B.S.,et al, 1982
Pure Red Cell Aplasia Associated with Sodium Valproate Therapy
JAMA 247:53-54, MacDougall,L.G.,et al, 1982
Current Status of Antifibrinolytic Therapy for Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage
Jr. , Stroke 13:256-259982., Adams,H.P., 1982
Amelioration of Hemiballismus with Sodium Valproate
Ann Neurol 12:407, Chandra,V.,et al, 1982
Aspirin as a Risk Factor in Reye's Syndrome
JAMA 247:3089-3094, Waldman,R.J.,et al, 1982
Reye's Syndrome & Medication Use
JAMA 248:687-691, Halpin,T.J.,et al, 1982
Treatment of Primary Reading Epilepsy With Valproic Acid
Arch Neurol 39:452-453, Vanderzant,C.,et al, 1982
Valproic Acid in the Treatment of Nonepileptic Myoclonus
Arch Neurol 39:448-449, Sotaniemi,K.,et al, 1982
Valproate & Clonazepam in the Treatment of Severe Progressive Myoclonus Epilepsy
Arch Neurol 39:236-238, Iivanainen,M.,et al, 1982
Asymptomatic Hyperammonemia in Patients Receiving Valproic Acid
Arch Neurol 39:591-592, Murphy,J.V.,et al, 1982
A Comparison of Phenytoin & Valproate in Previously Untreated Adult Epileptic Patients
JNNP 45:55-59, Turnbull,D.M.,et al, 1982
Serum Salicylate Concentrations In Reye's Disease
Lancet 1:191-193, Partin,J.S.,et al, 1982
Use of Valproic Acid in Treatment of Infantile Spasms
Arch Neurol 39:49-52, Bachman,D.S., 1982
Phenytoin-valproate Interaction:Importance of Saliva Monitoring in Epilepsy
BMJ 284:13-16, Knott,C.,et al, 1982
Valproic Acid Versus Ethosuximide in the Treatment of Absence Seizures
Neurol 32:157-163, Sato,S.,et al, 1982
Monitoring of Serum Amylase Levels During Valproic Acid Therapy
Ann Neurol 11:217-218, Bale,J.F.,et al, 1982
Acute Intracranial Hypertension & Nalidixic Acid Therapy
Neurol 32:212-215, Gedroyc,W.,et al, 1982
Valproic Acid, Treatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica
Arch Neurol 39:527-528, Sommerville,E.R.,et al, 1982